Mineralys Therapeutics Inc —— 财务报表 (NASDAQ:MLYS) | MetaTrader

展开完整图表

新闻

Jefferies因药物担忧下调Mineralys Therapeutics目标价

Jefferies cuts Mineralys Therapeutics price target on drug concerns

Mineralys: Big Pharma Threatens To Undermine Likely Hypertension Drug Approval (MLYS)

Stifel重申Mineralys股票买入评级,目标价52美元

Stifel reiterates Buy rating on Mineralys stock, $52 target

美国银行上调Mineralys Therapeutics目标价,因新药申请取得进展

BofA raises Mineralys Therapeutics stock price target on NDA progress

Mineralys Therapeutics, Inc. (MLYS) Q4 2025 Earnings Call Transcript

Mineralys财报受关注,FDA即将就lorundrostat作出决定

Mineralys earnings in focus as FDA lorundrostat decision looms

Mineralys Stock Rises as FDA Accepts NDA for Hypertension Drug

Stifel重申Mineralys Therapeutics评级,看好lorundrostat数据